T1	Organism 219 240	Plasmodium falciparum
T2	Organism 195 200	human
T3	Experiment 0 17	Phosphoproteomics
T4	Organism 32145 32158	P. falciparum
T5	Strain 32171 32187	3D7 (wild type)-
T6	Strain 32189 32197	PKGT618Q
T7	Strain 32203 32212	CDPK1-HA-
T8	Strain 32515 32523	PKGT618Q
T9	Strain 32528 32536	CDPK1-HA
T10	Time 33555 33556	8
T11	Time 33558 33560	16
T12	Time 33565 33567	24
T13	Time 33655 33657	32
T14	Time 33659 33661	40
T15	Time 33666 33668	48
T16	AlkylationReagent 51480 51493	Iodoacetamide
T17	CleavageAgent 51972 51979	trypsin
T18	Label 52096 52111	tandem mass tag
T19	Label 52123 52126	TMT
*	Equiv T18 T19
T20	Label 52249 52259	6-plex TMT
T21	Treatment 35935 35956	pHH4-CDPK1-HA plasmid
T22	CellType 50030 50039	schizonts
T23	Compound 50228 50238	Compound 2
T24	ConcentrationOfCompound 50240 50245	2 muM
T25	NumberOfSamples 50165 50168	two
T26	CleavageAgent 51159 51166	Tryptic
T27	Label 51181 51184	TMT
T32	FractionationMethod 52578 52610	Resource Q anion-exchange column
T33	FractionIdentifier 52846 52849	2-4
T34	FractionIdentifier 52895 52898	5-7
T35	FractionIdentifier 53127 53132	10-16
T36	FractionIdentifier 52822 52834	flow-through
T37	FractionIdentifier 52869 52873	wash
T38	FractionIdentifier 53090 53105	gradient eluate
T28	EnrichmentMethod 53195 53199	IMAC
T29	EnrichmentMethod 53223 53227	TiO2
T30	EnrichmentMethod 53205 53221	titanium dioxide
T31	EnrichmentMethod 53152 53193	immobilized metal affinity chromatography
T39	EnrichmentMethod 53260 53264	IMAC
T40	EnrichmentMethod 54318 54322	TiO2
*	Equiv T31 T28
*	Equiv T30 T29
T41	Instrument 55232 55250	LTQ-Orbitrap-Velos
T42	IonizationType 55919 55928	nanospray
T43	AcquisitionMethod 56409 56423	data-dependent
T44	FragmentationMethod 56424 56460	higher-energy collision dissociation
T45	FragmentationMethod 56462 56465	HCD
*	Equiv T44 T45
T46	PrecursorMassTolerance 56989 56997	10 p.p.m
T47	FragmentMassTolerance 57034 57041	0.02 Da
T48	Modification 57075 57097	carboxyamidomethyl (C)
A1	Modification T48 fixed
T49	Modification 57132 57145	oxidation (M)
A2	Modification T49 variable
T50	Modification 57150 57173	phosphorylation (S/T/Y)
A3	Modification T50 variable
T51	Compound 4524 4534	Compound 2
T52	Compound 4536 4633	4-[7-[(dimethylamino)-methyl]-2-(4-fluorphenyl)imidazo[1,2-alpha]pyridine-3-yl] pyrimidin-2-amine
*	Equiv T51 T52
T53	FactorValue 4524 4534	Compound 2
T54	FactorValue 50205 50238	presence or absence of Compound 2
T55	FactorValue 50228 50238	Compound 2
